Suchergebnisse - "Kale, Ramesh"

PubPharm (30)

1

Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling

enthalten in: Biomedical reports | 2023

von Kale, R. | Samant, C. | Bokare, A. | +3

2

PAK4 inhibition significantly potentiates Gemcitabine activity in PDAC cells via inhibition of Wnt/β-catenin, p-ERK/MAPK and p-AKT/PI3K pathways

enthalten in: Biochemistry and biophysics reports | 2023

von Samant, C. | Kale, R. | Bokare, A. | +3

3

Dual PI3Kδγ inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models : Discovery and preclinical characterization of LL-00084282

enthalten in: Biochemical and biophysical research communications | 2022

von Verma, M. | Samant, C. | Kale, R. | +28

4

Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly(ADP-ribose) polymerase-1 (PARP1) as anticancer agents : Structure activity relationship and preclinical characterization

enthalten in: Bioorganic & medicinal chemistry | 2020

von Karche, N. | Bhonde, M. | Sinha, N. | +52

5

Structural insights into Escherichia coli phosphopantothenoylcysteine synthetase by native ion mobility-mass spectrometry

enthalten in: The Biochemical journal | 2019

von Chan, D. | Hess, J. | Shaw, E. | +9

6

COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS

enthalten in: Europäisches Patentamt | 2015

von RATAN KALE RAMESH | MADHAVAPEDDI PRASHANTI | RAGHUNATH GHORPADE SANDEEP | +8

7

Thiazolopyridone ureas as DNA gyrase B inhibitors : optimization of antitubercular activity and efficacy

enthalten in: Bioorganic & medicinal chemistry letters | 2014

von Kale, R. | Kale, M. | Waterson, D. | +24

8

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy

enthalten in: Bioorganic & medicinal chemistry letters | 2014

von Kale, R. | Kale, M. | Waterson, D. | +24

9

Azaindoles : noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo

enthalten in: Journal of medicinal chemistry | 2013

von Shirude, P. | Shandil, R. | Sadler, C. | +36

10

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo

enthalten in: Journal of medicinal chemistry | 2013

von Shirude, P. | Shandil, R. | Sadler, C. | +36